Phase II Study of Neoadjuvant FOLFIRINOX in Patients with Non-Metastatic Pancreatic Cancer
The purpose of this phase II study is to evaluate the safety and efficacy of neoadjuvant FOLFIRINOX in patients with untreated pancreatic cancer.
Study ID: LCCC1843
Trial Phase: Phase II
Trial Sponsor: UNC Lineberger Comprehensive Cancer Center
Therapies Used in This Trial: FOLFIRINOX